<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Cell Infect Microbiol</journal-id><journal-id journal-id-type="iso-abbrev">Front Cell Infect Microbiol</journal-id><journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id><journal-title-group><journal-title>Frontiers in Cellular and Infection Microbiology</journal-title></journal-title-group><issn pub-type="epub">2235-2988</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">31867289</article-id><article-id pub-id-type="pmc">6904278</article-id><article-id pub-id-type="doi">10.3389/fcimb.2019.00415</article-id><article-categories><subj-group subj-group-type="heading"><subject>Cellular and Infection Microbiology</subject><subj-group><subject>Mini Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Current Understanding of the Acute Exacerbation of Chronic Rhinosinusitis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Wu</surname><given-names>Dawei</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/482599/overview"/></contrib><contrib contrib-type="author"><name><surname>Bleier</surname><given-names>Benjamin Saul</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/498049/overview"/></contrib><contrib contrib-type="author"><name><surname>Wei</surname><given-names>Yongxiang</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="c001"><sup>*</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/516006/overview"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Department of Otolaryngology-Head and Neck Surgery, Beijing Anzhen Hospital, Capital Medical University</institution>, <addr-line>Beijing</addr-line>, <country>China</country></aff><aff id="aff2"><sup>2</sup><institution>Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Harvard Medical School</institution>, <addr-line>Boston, MA</addr-line>, <country>United States</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Sarah Vreugde, University of Adelaide, Australia</p></fn><fn fn-type="edited-by"><p>Reviewed by: Richard George Douglas, The University of Auckland, New Zealand; Emily K. Cope, Northern Arizona University, United States</p></fn><corresp id="c001">*Correspondence: Yongxiang Wei <email>yongxw67@163.com</email></corresp><fn fn-type="other" id="fn001"><p>This article was submitted to Clinical Microbiology, a section of the journal Frontiers in Cellular and Infection Microbiology</p></fn></author-notes><pub-date pub-type="epub"><day>04</day><month>12</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>9</volume><elocation-id>415</elocation-id><history><date date-type="received"><day>22</day><month>8</month><year>2019</year></date><date date-type="accepted"><day>20</day><month>11</month><year>2019</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2019 Wu, Bleier and Wei.</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Wu, Bleier and Wei</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p><bold>Background:</bold> Acute exacerbations of chronic rhinosinusitis (CRS) have been increasingly recognized as an important disease entity with a significant impact on the quality of life. There is a growing amount of research on the etiopathogenesis and management of acute exacerbations of CRS. This review aims to summarize the current literature and provide an overall understanding of acute CRS exacerbations.</p><p><bold>Methods:</bold> A related literature review with the key terms of &#x0201c;chronic rhinosinusitis&#x0201d; and &#x0201c;exacerbation&#x0201d; was performed using PubMed.</p><p><bold>Results:</bold> There is no consensus definition of the acute exacerbation of CRS. Impaired mucociliary clearance, atrophic rhinitis, and immunologic changes are important predisposing factors for acute CRS exacerbations. Current evidence supports the role of the transient viral infection as the initial inflammatory stimulus in the pathogenesis of acute CRS exacerbations. Secondary bacterial infection or microbial community dysbiosis within the sinonasal cavity is the main event during the acute exacerbation of CRS. Distinct changes in local and systemic immune responses during exacerbation provide new insights into the pathophysiology of CRS exacerbation. Although current guidelines suggest the use of short-term antibiotics in patients with acute CRS exacerbation for symptomatic relief, evidence-based treatment recommendations for acute CRS exacerbation are still lacking, and large-high-quality RCTs are required.</p><p><bold>Conclusion:</bold> There have been significant advances in understanding the etiology and immunological feathers of acute CRS exacerbation. Nevertheless, consensus definition, diagnostic criterion, biomarkers to differentiate acute CRS exacerbation from CRS, assessment of disease severity, and evidence-based treatment options for acute CRS exacerbation are still lacking.</p></abstract><kwd-group><kwd>Chronic rhinosinusitis</kwd><kwd>acute exacerbations</kwd><kwd>bacteria</kwd><kwd>virus</kwd><kwd>etiology</kwd><kwd>treatment</kwd></kwd-group><counts><fig-count count="0"/><table-count count="0"/><equation-count count="0"/><ref-count count="72"/><page-count count="6"/><word-count count="5320"/></counts></article-meta></front><body><sec sec-type="intro" id="s1"><title>Introduction</title><p>Chronic rhinosinusitis (CRS) is a highly heterogeneous upper airway disease (Orlandi et al., <xref rid="B46" ref-type="bibr">2016</xref>), which affects about 11&#x02013;12% of adults in western countries (Hastan et al., <xref rid="B29" ref-type="bibr">2011</xref>; Hirsch et al., <xref rid="B30" ref-type="bibr">2017</xref>) and ~8% of the general population in China (Shi et al., <xref rid="B59" ref-type="bibr">2015</xref>). It significantly impairs quality of life due to the chronic symptoms (Hoehle et al., <xref rid="B31" ref-type="bibr">2016</xref>) and acute exacerbations of CRS (Phillips et al., <xref rid="B49" ref-type="bibr">2017</xref>). Notably, one significant issue related to the care of CRS patients is concerning the acute exacerbations, which might account for increasing healthcare cost (Chung et al., <xref rid="B17" ref-type="bibr">2014</xref>; Smith et al., <xref rid="B61" ref-type="bibr">2015</xref>) and annual physician visits (Smith et al., <xref rid="B62" ref-type="bibr">2013</xref>), as well as significant decreases in workplace productivity (Rudmik et al., <xref rid="B56" ref-type="bibr">2014</xref>; Campbell et al., <xref rid="B13" ref-type="bibr">2017</xref>). An acute exacerbation of CRS is defined as an acute and transient worsening of preexisting symptoms in patients with CRS (Fokkens et al., <xref rid="B23" ref-type="bibr">2012</xref>), and the frequency of CRS exacerbations is recently identified as an independent predictor of quality of life (Phillips et al., <xref rid="B49" ref-type="bibr">2017</xref>). Currently, triggers leading to CRS disease exacerbation are not well-characterized. However, patients with acute CRS exacerbation are mainly attributed to the bacterial infection, and therefore they are treated as acute rhinosinusitis with antibiotics in the leading guidelines (Fokkens et al., <xref rid="B23" ref-type="bibr">2012</xref>; Peters et al., <xref rid="B48" ref-type="bibr">2014</xref>; Banoub et al., <xref rid="B3" ref-type="bibr">2018</xref>).</p><p>There are accumulating evidence supporting the critical role of sinus mucosal microbiome in the pathogenesis of CRS (Hamilos, <xref rid="B27" ref-type="bibr">2014</xref>; Brook, <xref rid="B11" ref-type="bibr">2016</xref>; Mahdavinia et al., <xref rid="B41" ref-type="bibr">2016</xref>; Wagner et al., <xref rid="B66" ref-type="bibr">2017</xref>; Sivasubramaniam and Douglas, <xref rid="B60" ref-type="bibr">2018</xref>), either as a direct driver of chronic inflammation (Hamilos, <xref rid="B28" ref-type="bibr">2015</xref>; Lan et al., <xref rid="B37" ref-type="bibr">2018</xref>; Lee et al., <xref rid="B38" ref-type="bibr">2018</xref>) or as being potentially involved in its exacerbation (Wood et al., <xref rid="B69" ref-type="bibr">2011</xref>; Tan et al., <xref rid="B64" ref-type="bibr">2017</xref>). The etiology of acute CRS exacerbation is usually a secondary bacterial infection that commonly begins with a viral upper respiratory tract infection (Cho et al., <xref rid="B16" ref-type="bibr">2013</xref>; Rowan et al., <xref rid="B54" ref-type="bibr">2015</xref>) or begins with microbial community dysbiosis within the sinonasal cavity (Brook et al., <xref rid="B12" ref-type="bibr">2005</xref>; Brook, <xref rid="B10" ref-type="bibr">2006</xref>). Furthermore, the acute exacerbations of CRS after endoscopic surgery are highly associated with bacterial infections (Bhattacharyya and Kepnes, <xref rid="B8" ref-type="bibr">1999</xref>; Bhattacharyya et al., <xref rid="B6" ref-type="bibr">2004</xref>; Ikeda et al., <xref rid="B34" ref-type="bibr">2011</xref>). Although viral and bacterial infections are the main event during the process of acute exacerbation, factors influencing the dynamics of the nasal microbiota, pathogenic mechanisms exerted by microbial dysbiosis, and the association between the nasal microbiota and outer stimuli remain unclear. Recent studies have proved that patients with acute CRS exacerbation have distinct immunological changes (Rank et al., <xref rid="B51" ref-type="bibr">2013</xref>; Divekar et al., <xref rid="B20" ref-type="bibr">2015</xref>), and a series of risk factors for the acute exacerbations of CRS have been identified (Kuiper et al., <xref rid="B36" ref-type="bibr">2018</xref>), which promotes the understanding of the complex pathogenesis of acute CRS exacerbation. This review will summarize the current knowledge on clinical and immunologic characteristics and medical treatment of acute CRS exacerbation.</p></sec><sec id="s2"><title>Definition of Acute Exacerbation of Chronic Rhinosinusitis</title><p>There is no consensus definition of an acute exacerbation of CRS mainly due to the inconsistency in reporting of endpoints and the complex etiology of acute exacerbation. The International Consensus Statement on Allergy and Rhinology put forward the definition of AECRS that a sudden worsening of symptoms in a patient previously diagnosed with CRS, with a return to baseline symptoms after treatment (Orlandi et al., <xref rid="B46" ref-type="bibr">2016</xref>). Similarly, the European Position Paper on Rhinosinusitis and Nasal Polyps 2012 (EPOS 2012) defined the AECRS based on the sudden worsening of preexisting sinonasal symptoms in patients with CRS (Fokkens et al., <xref rid="B23" ref-type="bibr">2012</xref>). Furthermore, several empirical definition criteria have been widely used for research purposes. A study from Rank and colleagues defined a CRS exacerbation based on diagnosis coding and at least one of the following: a prescription for systemic antibiotics, systemic corticosteroids, plans for surgical intervention, emergency department or urgent care visit, or hospitalization for CRS (Rank et al., <xref rid="B52" ref-type="bibr">2010</xref>). Similarly, Sedaghat and colleagues used three described metrics to assess the exacerbation frequency of CRS, the number of patient-reported (1) sinus infections, (2) CRS-related antibiotic courses, and (3) CRS-related oral corticosteroid courses, each in the last 3 months (Phillips et al., <xref rid="B49" ref-type="bibr">2017</xref>; Banoub et al., <xref rid="B3" ref-type="bibr">2018</xref>; Yamasaki et al., <xref rid="B70" ref-type="bibr">2018</xref>). These direct treatment-related metrics of acute CRS exacerbation facilitate the quantitative research and assessment on the acute exacerbation of CRS, although there is a certain discrepancy between these metrics. It is necessary to put forward a well-recognized diagnostic criterion that contains either symptom-based or actual examination-based items.</p><p>It is also important to point out that recurrent acute rhinosinusitis (RARS), which shares a variety of symptoms with acute CRS exacerbation, is a distinct form of rhinosinusitis regarding anatomic variants (Sohn et al., <xref rid="B63" ref-type="bibr">2018</xref>) and the number of previous sinus surgery (Poetker et al., <xref rid="B50" ref-type="bibr">2008</xref>). RARS is defined by a threshold of 4 episodes of acute bacterial rhinosinusitis per year (Poetker et al., <xref rid="B50" ref-type="bibr">2008</xref>; Bhattacharyya et al., <xref rid="B7" ref-type="bibr">2012</xref>; Rosenfeld et al., <xref rid="B53" ref-type="bibr">2015</xref>), and patients with RARS experience complete resolution of sinus-specific symptoms and have completed resolved sinus changes between episodes of acute bacterial rhinosinusitis (Barham et al., <xref rid="B4" ref-type="bibr">2017</xref>). Furthermore, an appropriateness criterion for endoscopic sinus surgery in the management of adult RARS has been recently proposed to optimize the quality and value of surgical inventions (Rudmik et al., <xref rid="B55" ref-type="bibr">2018</xref>).</p></sec><sec id="s3"><title>Predisposing Factors for Acute CRS Exacerbations</title><p>Previous studies have focused on the mechanisms of CRS (Bachert et al., <xref rid="B2" ref-type="bibr">2018</xref>; Cao et al., <xref rid="B14" ref-type="bibr">2018</xref>), and the etiology of acute CRS exacerbation is not well-identified (Orlandi et al., <xref rid="B46" ref-type="bibr">2016</xref>). There has been an increasing consensus that predisposing conditions including allergic rhinitis, nasal deformity, immune deficiency, and other environmental factors create an environment conducive to the viral infection (Tan et al., <xref rid="B64" ref-type="bibr">2017</xref>) and the subsequent growth of bacteria (Brook, <xref rid="B10" ref-type="bibr">2006</xref>; Ikeda et al., <xref rid="B34" ref-type="bibr">2011</xref>; Bose et al., <xref rid="B9" ref-type="bibr">2016</xref>), leading to acute exacerbations. CRS is characterized by a dysfunctional host-environmental interaction both in the epithelium and the subsequent immune response (Tieu et al., <xref rid="B65" ref-type="bibr">2009</xref>; Fokkens et al., <xref rid="B23" ref-type="bibr">2012</xref>; Schleimer, <xref rid="B58" ref-type="bibr">2017</xref>). Therefore, there are some certain defects of host immune response associated with CRS predispose to acute CRS exacerbation when the triggers are involved. It has been reported that impaired mucociliary clearance and atrophic rhinitis in combination with CRS are important predisposing factors for acute CRS exacerbations (Hafner et al., <xref rid="B26" ref-type="bibr">1997</xref>; Fokkens et al., <xref rid="B23" ref-type="bibr">2012</xref>; Dutta and Ghatak, <xref rid="B21" ref-type="bibr">2013</xref>).</p></sec><sec id="s4"><title>Initiating Role of the Virus in the Acute CRS Exacerbation</title><p>Similar to the initiating role of the virus in the exacerbation of acute rhinosinusitis (Eloy et al., <xref rid="B22" ref-type="bibr">2011</xref>; Fokkens et al., <xref rid="B23" ref-type="bibr">2012</xref>), there is evidence supporting the crucial role of the virus in the acute CRS exacerbation and rhinovirus is the most prevalent virus in patients with CRS exacerbation (Cho et al., <xref rid="B16" ref-type="bibr">2013</xref>; Rowan et al., <xref rid="B54" ref-type="bibr">2015</xref>). A recent systematic review by Basharat et al. showed that the prevalence of rhinovirus infections is increased in patients with CRS. Furthermore, rhinovirus infections incite inflammatory reactions that may result in CRS exacerbations and progression of disease (Basharat et al., <xref rid="B5" ref-type="bibr">2019</xref>). Human bocavirus and metapneumovirus (hMPV) are also found in the nasal washes of CRS during flare-ups (Tan et al., <xref rid="B64" ref-type="bibr">2017</xref>). Moreover, some other viruses, such as herpes virus, human cytomegalovirus, and Epstein-Barr virus, have identified in patients with nasal polyps, and it is still unclear whether they contribute to the acute CRS exacerbations (Costa et al., <xref rid="B19" ref-type="bibr">2014</xref>). Previous <italic>in vitro</italic> studies have shown that respiratory viral infection can facilitate the invasion of bacteria into the nasal mucosa through directly damaging to the epithelial cells and impairing tight junctions (Yeo and Jang, <xref rid="B71" ref-type="bibr">2010</xref>; Wang et al., <xref rid="B68" ref-type="bibr">2012</xref>). Furthermore, viral infections have been reported to obstruct sinus ostia (Gwaltney et al., <xref rid="B25" ref-type="bibr">1994</xref>), production of inflammatory mediators by nasal epithelial cells (Wang et al., <xref rid="B67" ref-type="bibr">2009</xref>), and damage to the cilia (Pedersen et al., <xref rid="B47" ref-type="bibr">1983</xref>). It has been proposed that the priming of the nasal epithelium against acute viral infection potentiates its environment to be suitable for secondary bacterial infection, which may further exacerbate the symptoms (Tan et al., <xref rid="B64" ref-type="bibr">2017</xref>).</p><p>It should also be noted that most acute viral infections in patients with CRS are self-limiting, and the duration of symptoms lasts &#x0003c;10 days (Orlandi et al., <xref rid="B46" ref-type="bibr">2016</xref>). Interestingly, several studies have pointed out that viral colonization did not increase the viral infection rate in patients with CRS compared with controls (Liao et al., <xref rid="B39" ref-type="bibr">2014</xref>), and the persistence of respiratory viruses within sinonasal mucosa is unlikely to be a cause of ongoing inflammation in CRS (Wood et al., <xref rid="B69" ref-type="bibr">2011</xref>) but play an essential role in the symptom exacerbation in patients with CRS (Rowan et al., <xref rid="B54" ref-type="bibr">2015</xref>). All this evidence supports the role of the transient viral infection as the initial inflammatory stimulus in the pathogenesis of acute CRS exacerbations. However, it is relatively harder to identify key viruses that exacerbate CRS compared to ARS due to the multifactorial nature of CRS exacerbation.</p></sec><sec id="s5"><title>Bacteriology in the Acute CRS Exacerbation</title><p>While bacteria may trigger acute infectious exacerbations (Bose et al., <xref rid="B9" ref-type="bibr">2016</xref>), the role of bacteria in acute CRS exacerbation is not completely understood. The most commonly cultured microbiota during acute exacerbations of CRS included <italic>Staphylococcus aureus, Pseudomonas aeruginosa</italic>, and other common pathogens (<italic>Streptococcus pneumonia, Haemophilus influenza, Moraxella catarrhalis, or Streptococcus pyogenes</italic>) (Cincik and Ferguson, <xref rid="B18" ref-type="bibr">2006</xref>; Liu et al., <xref rid="B40" ref-type="bibr">2013</xref>). Besides, <italic>S. pneumoniae</italic> and <italic>H. influenzae</italic> were found more frequently in patients with acute CRS exacerbation compared to those with CRS without frequent acute exacerbations (Brook, <xref rid="B10" ref-type="bibr">2006</xref>). Also, the identified organisms were predominantly anaerobic, which was similar to those generally identified in CRS (<italic>Prevotella, Porhyromonas, Peptostreptococcus, and Fusobacterium subspecies</italic>). A study by Merkley et al. concluded that bacterial abundance was increased, but diversity was decreased during acute exacerbations of CRS (Merkley et al., <xref rid="B42" ref-type="bibr">2015</xref>). These studies support the hypothesis of microbial imbalance as a critical driver of acute CRS exacerbation.</p><p>As a chronic inflammatory airway disease, CRS is characterized by mucosal microbiota dysbiosis (Lee et al., <xref rid="B38" ref-type="bibr">2018</xref>). Under a specific predisposing condition, patients with CRS experience acute and transient alternations of the mucosal microbiota, which may contribute to the sinus infection. It has been well-recognized that viral infection plays an initiating role in the pathogenesis of acute CRS exacerbation, and a bacterial infection occurs as the secondary event. It can be speculated that the host response to viral infection is likely to influence susceptibility to acute CRS exacerbation. A better understanding of the biologic mechanisms of host susceptibility to viral infection will be crucial for developing more effective preventions and treatments aimed at improving the quality of life and thereby reducing the high cost in patients with CRS.</p></sec><sec id="s6"><title>Immunological Feathers of acute Exacerbation of CRS</title><p>Acute exacerbation of CRS is increasingly being recognized as a distinct clinical manifestation of CRS that should be routinely evaluated in patients with CRS (Divekar et al., <xref rid="B20" ref-type="bibr">2015</xref>; Banoub et al., <xref rid="B3" ref-type="bibr">2018</xref>). Immunologic changes that occur during exacerbation may help physicians understand the pathogenesis of this acute phase of CRS. Rank and colleagues found that the levels of IL-6, eosinophil major basic protein (MBP), myeloperoxidase (MPO), eosinophil-derived neurotoxin, and uric acid in nasal secretion samples during CRSwNP exacerbation were significantly elevated when compared with the baseline measurements (Rank et al., <xref rid="B51" ref-type="bibr">2013</xref>). What is more, the level of IL-6 significantly and positively correlated with both the levels of MBP and MPO. Increased IL-6 response has been associated with the onset of the viral upper respiratory tract infection in healthy individuals or virus-induced asthma exacerbations (Zhu et al., <xref rid="B72" ref-type="bibr">1996</xref>; Jackson and Johnston, <xref rid="B35" ref-type="bibr">2010</xref>). An epidemiological study also indicated that acute exacerbations of chronic rhinosinusitis occurred in the winter season during which viral infections are known to be prevalent, which implied a potential relationship between CRS disease activity and viral infection (Rank et al., <xref rid="B52" ref-type="bibr">2010</xref>).</p><p>Systemic immune responses during exacerbation in patients with CRSwNP were also explored (Divekar et al., <xref rid="B20" ref-type="bibr">2015</xref>). It showed that vascular endothelial growth factor (VEGF) and granulocyte&#x02013;macrophage colony-stimulating factor (GM-CSF) levels in serum were significantly increased in CRSwNP patients during exacerbation when compared to control subjects or their baseline values. As the fact that VEGF and GM-CSF may play essential roles in tissue remodeling, and innate and adaptive immunity of nasal and sinus mucosa, future studies are warranted to investigate their exact role in the pathological changes in patients with CRS during exacerbation. These works have provided new insights into the pathophysiology of CRSwNP exacerbation. However, it should also be pointed out that the animal model of CRS with acute exacerbation is still lacking, and a new model would be helpful to elucidate its pathophysiological mechanism.</p></sec><sec id="s7"><title>Current Medical Treatment for Patients with Acute CRS Exacerbation</title><p>Current guidelines recommend the use of short-term antibiotics in patients with acute CRS exacerbation for symptomatic relief (Fokkens et al., <xref rid="B23" ref-type="bibr">2012</xref>; Peters et al., <xref rid="B48" ref-type="bibr">2014</xref>; Orlandi et al., <xref rid="B46" ref-type="bibr">2016</xref>). Non-macrolide antibiotics (i.e., cefuroxime, ofloxacin, cefixime, amoxicillin with or without clavulanic acid) comprises the mainstay of the short-term antibacterial therapy in CRS patients with the most significant benefit in CRS exacerbations with a positive culture (Gehanno and Cohen, <xref rid="B24" ref-type="bibr">1993</xref>; Huck et al., <xref rid="B33" ref-type="bibr">1993</xref>; Namyslowski et al., <xref rid="B44" ref-type="bibr">2002</xref>; Adelson and Adappa, <xref rid="B1" ref-type="bibr">2013</xref>; Hoza et al., <xref rid="B32" ref-type="bibr">2013</xref>). There is only one RCT study about the antibiotics treatment of acute CRS exacerbation (Sabino et al., <xref rid="B57" ref-type="bibr">2017</xref>). It showed that amoxicillin-clavulanate for 14 days did not change the clinical course of acute CRS exacerbation compared with placebo and the addition of an oral antibiotic to ongoing topical intranasal steroid spray did not provide additional benefit during the management of acute CRS exacerbation. The study also pointed out that the sample size (<italic>n</italic> = 21) was relatively small, which might lead to the inherent risks of committing biased conclusions. A recent review has discussed the role of macrolide treatment in patients with acute CRS exacerbation (Oakley et al., <xref rid="B45" ref-type="bibr">2017</xref>). The high-dose macrolide antibiotics are typically involved in the treatment of acute CRS exacerbation, especially in penicillin-allergic patients, and a therapeutic dose is usually administered for 10 days. However, the current literature about the macrolide therapy that focused on the acute CRS exacerbation is still lacking, and further studies are needed in the future. In addition to antibiotic treatment, other medical treatment has also been reported. A retrospective study by Chaudhry et al. showed that topical triamcinolone acetonide (TA) and carboxymethylcellulose (CMC) foam for acute exacerbation of CRSwNP could significantly decrease SNOT-22 scores and the overall prednisone use in postoperative CRSwNP patients (Chaudhry et al., <xref rid="B15" ref-type="bibr">2014</xref>). A recent review by Miyake and Bleier pointed out that topical medications might have an advantage over oral antibiotics for the treatment of acute CRS exacerbations (Miyake and Bleier, <xref rid="B43" ref-type="bibr">2019</xref>). Lacking evidence-based treatment recommendations for acute CRS exacerbation, therefore, requires further studies on this disease status, and large-high-quality RCTs would help determine the best medical therapy to manage patients with acute CRS exacerbation.</p></sec><sec id="s8"><title>Conclusion and Future Research Direction</title><p>Acute CRS exacerbation has gained increasing attention due to its significant influence on patients' quality of life and healthcare cost. As a distinct form of CRS, acute CRS exacerbation can be triggered by viruses and then follows with bacterial infections, which might be the result caused by the imbalance among the bacterial species within the sinus cavities. There have been significant advances in understanding the etiology and immunological feathers of acute CRS exacerbation. Nevertheless, consensus definition, diagnostic criterion, biomarkers to differentiate acute CRS exacerbation from CRS, assessment of disease severity, and evidence-based treatment options for acute CRS exacerbation are still lacking.</p></sec><sec id="s9"><title>Author Contributions</title><p>DW drafted the manuscript. BB and YW reviewed and revised this manuscript.</p><sec><title>Conflict of Interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></sec></body><back><fn-group><fn fn-type="financial-disclosure"><p><bold>Funding.</bold> This study was supported by the Natural Science Foundation of China (81670903), Capital Health Research and Development of Special Fund (2018-2-2065), Beijing Municipal Administration of Hospitals Ascent Plan (DFL20150602), Beijing Key Laboratory of upper airway dysfunction related cardiovascular diseases (BZ0377), and Beijing Hospitals Authority Youth Programme (QML20190617).</p></fn></fn-group><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adelson</surname><given-names>R. T.</given-names></name><name><surname>Adappa</surname><given-names>N. D.</given-names></name></person-group> (<year>2013</year>). <article-title>What is the proper role of oral antibiotics in the treatment of patients with chronic sinusitis?</article-title>
<source>Curr. Opin. Otolaryngol. Head Neck Surg.</source>
<volume>21</volume>, <fpage>61</fpage>&#x02013;<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1097/MOO.0b013e32835ac625</pub-id><pub-id pub-id-type="pmid">23299120</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bachert</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>N.</given-names></name><name><surname>Hellings</surname><given-names>P. W.</given-names></name><name><surname>Bousquet</surname><given-names>J.</given-names></name></person-group> (<year>2018</year>). <article-title>Endotype-driven care pathways in patients with chronic rhinosinusitis</article-title>. <source>J. Allergy Clin. Immunol.</source>
<volume>141</volume>, <fpage>1543</fpage>&#x02013;<lpage>1551</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaci.2018.03.004</pub-id><pub-id pub-id-type="pmid">29731100</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banoub</surname><given-names>R. G.</given-names></name><name><surname>Phillips</surname><given-names>K. M.</given-names></name><name><surname>Hoehle</surname><given-names>L. P.</given-names></name><name><surname>Caradonna</surname><given-names>D. S.</given-names></name><name><surname>Gray</surname><given-names>S. T.</given-names></name><name><surname>Sedaghat</surname><given-names>A. R.</given-names></name></person-group> (<year>2018</year>). <article-title>Relationship between chronic rhinosinusitis exacerbation frequency and asthma control</article-title>. <source>Laryngoscope</source>
<volume>128</volume>, <fpage>1033</fpage>&#x02013;<lpage>1038</lpage>. <pub-id pub-id-type="doi">10.1002/lary.26901</pub-id><pub-id pub-id-type="pmid">28963721</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barham</surname><given-names>H. P.</given-names></name><name><surname>Zhang</surname><given-names>A. S.</given-names></name><name><surname>Christensen</surname><given-names>J. M.</given-names></name><name><surname>Sacks</surname><given-names>R.</given-names></name><name><surname>Harvey</surname><given-names>R. J.</given-names></name></person-group> (<year>2017</year>). <article-title>Acute radiology rarely confirms sinus disease in suspected recurrent acute rhinosinusitis</article-title>. <source>Int. Forum Allergy Rhinol.</source>
<volume>7</volume>, <fpage>726</fpage>&#x02013;<lpage>733</lpage>. <pub-id pub-id-type="doi">10.1002/alr.21925</pub-id><pub-id pub-id-type="pmid">28494137</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basharat</surname><given-names>U.</given-names></name><name><surname>Aiche</surname><given-names>M. M.</given-names></name><name><surname>Kim</surname><given-names>M. M.</given-names></name><name><surname>Sohal</surname><given-names>M.</given-names></name><name><surname>Chang</surname><given-names>E. H.</given-names></name></person-group> (<year>2019</year>). <article-title>Are rhinoviruses implicated in the pathogenesis of sinusitis and chronic rhinosinusitis exacerbations? A comprehensive review</article-title>. <source>Int. Forum Allergy Rhinol.</source>
<volume>9</volume>, <fpage>1159</fpage>&#x02013;<lpage>1188</lpage>. <pub-id pub-id-type="doi">10.1002/alr.22403</pub-id><pub-id pub-id-type="pmid">31430424</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhattacharyya</surname><given-names>N.</given-names></name><name><surname>Gopal</surname><given-names>H. V.</given-names></name><name><surname>Lee</surname><given-names>K. H.</given-names></name></person-group> (<year>2004</year>). <article-title>Bacterial infection after endoscopic sinus surgery: a controlled prospective study</article-title>. <source>Laryngoscope</source>
<volume>114</volume>, <fpage>765</fpage>&#x02013;<lpage>767</lpage>. <pub-id pub-id-type="doi">10.1097/00005537-200404000-00032</pub-id><pub-id pub-id-type="pmid">15064638</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhattacharyya</surname><given-names>N.</given-names></name><name><surname>Grebner</surname><given-names>J.</given-names></name><name><surname>Martinson</surname><given-names>N. G.</given-names></name></person-group> (<year>2012</year>). <article-title>Recurrent acute rhinosinusitis: epidemiology and health care cost burden</article-title>. <source>Otolaryngology</source>
<volume>146</volume>, <fpage>307</fpage>&#x02013;<lpage>312</lpage>. <pub-id pub-id-type="doi">10.1177/0194599811426089</pub-id><pub-id pub-id-type="pmid">22027867</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhattacharyya</surname><given-names>N.</given-names></name><name><surname>Kepnes</surname><given-names>L. J.</given-names></name></person-group> (<year>1999</year>). <article-title>The microbiology of recurrent rhinosinusitis after endoscopic sinus surgery</article-title>. <source>Arch. Otolaryngol.</source>
<volume>125</volume>, <fpage>1117</fpage>&#x02013;<lpage>1120</lpage>. <pub-id pub-id-type="doi">10.1001/archotol.125.10.1117</pub-id><pub-id pub-id-type="pmid">10522504</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bose</surname><given-names>S.</given-names></name><name><surname>Grammer</surname><given-names>L. C.</given-names></name><name><surname>Peters</surname><given-names>A. T.</given-names></name></person-group> (<year>2016</year>). <article-title>Infectious chronic rhinosinusitis</article-title>. <source>J. Allergy Clin. Immunol.</source>
<volume>4</volume>, <fpage>584</fpage>&#x02013;<lpage>589</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaip.2016.04.008</pub-id><pub-id pub-id-type="pmid">27393772</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brook</surname><given-names>I.</given-names></name></person-group> (<year>2006</year>). <article-title>Bacteriology of chronic sinusitis and acute exacerbation of chronic sinusitis</article-title>. <source>Arch. Otolaryngol.</source>
<volume>132</volume>, <fpage>1099</fpage>&#x02013;<lpage>1101</lpage>. <pub-id pub-id-type="doi">10.1001/archotol.132.10.1099</pub-id><pub-id pub-id-type="pmid">17043258</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brook</surname><given-names>I.</given-names></name></person-group> (<year>2016</year>). <article-title>Microbiology of chronic rhinosinusitis</article-title>. <source>Eur. J. Clin. Microbiol. Infect. Dis.</source>
<volume>35</volume>, <fpage>1059</fpage>&#x02013;<lpage>1068</lpage>. <pub-id pub-id-type="doi">10.1007/s10096-016-2640-x</pub-id><pub-id pub-id-type="pmid">27086363</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brook</surname><given-names>I.</given-names></name><name><surname>Foote</surname><given-names>P. A.</given-names></name><name><surname>Frazier</surname><given-names>E. H.</given-names></name></person-group> (<year>2005</year>). <article-title>Microbiology of acute exacerbation of chronic sinusitis</article-title>. <source>Ann. Otol. Rhinol. Laryngol.</source>
<volume>114</volume>, <fpage>573</fpage>&#x02013;<lpage>576</lpage>. <pub-id pub-id-type="doi">10.1177/000348940511400714</pub-id><pub-id pub-id-type="pmid">16134356</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campbell</surname><given-names>A. P.</given-names></name><name><surname>Phillips</surname><given-names>K. M.</given-names></name><name><surname>Hoehle</surname><given-names>L. P.</given-names></name><name><surname>Feng</surname><given-names>A. L.</given-names></name><name><surname>Bergmark</surname><given-names>R. W.</given-names></name><name><surname>Caradonna</surname><given-names>D. S.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>Depression symptoms and lost productivity in chronic rhinosinusitis</article-title>. <source>Ann. Allergy Asthma Immunol.</source>
<volume>118</volume>, <fpage>286</fpage>&#x02013;<lpage>289</lpage>. <pub-id pub-id-type="doi">10.1016/j.anai.2016.12.012</pub-id><pub-id pub-id-type="pmid">28284535</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>P.-P.</given-names></name><name><surname>Wang</surname><given-names>Z.-C.</given-names></name><name><surname>Schleimer</surname><given-names>R. P.</given-names></name><name><surname>Liu</surname><given-names>Z.</given-names></name></person-group> (<year>2018</year>). <article-title>Pathophysiologic mechanisms of chronic rhinosinusitis and their roles in emerging disease endotypes</article-title>. <source>Ann. Allergy Asthma Immunol</source>. <volume>122</volume>, <fpage>33</fpage>&#x02013;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1016/j.anai.2018.10.014</pub-id><pub-id pub-id-type="pmid">30326322</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaudhry</surname><given-names>A. L.</given-names></name><name><surname>Chaaban</surname><given-names>M. R.</given-names></name><name><surname>Ranganath</surname><given-names>N. K.</given-names></name><name><surname>Woodworth</surname><given-names>B. A.</given-names></name></person-group> (<year>2014</year>). <article-title>Topical triamcinolone acetonide/carboxymethylcellulose foam for acute exacerbations of chronic rhinosinusitis/nasal polyposis</article-title>. <source>Am. J. Rhinol. Allergy</source>
<volume>28</volume>, <fpage>341</fpage>&#x02013;<lpage>344</lpage>. <pub-id pub-id-type="doi">10.2500/ajra.2014.28.4053</pub-id><pub-id pub-id-type="pmid">24819563</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>G. S.</given-names></name><name><surname>Moon</surname><given-names>B.-J.</given-names></name><name><surname>Lee</surname><given-names>B.-J.</given-names></name><name><surname>Gong</surname><given-names>C.-H.</given-names></name><name><surname>Kim</surname><given-names>N. H.</given-names></name><name><surname>Kim</surname><given-names>Y.-S.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>High rates of detection of respiratory viruses in the nasal washes and mucosae of the patients with chronic rhinosinusitis</article-title>. <source>J. Clin. Microbiol</source>. <volume>51</volume>, <fpage>979</fpage>&#x02013;<lpage>984</lpage>. <pub-id pub-id-type="doi">10.1128/JCM.02806-12</pub-id><pub-id pub-id-type="pmid">23325817</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname><given-names>S. D.</given-names></name><name><surname>Hung</surname><given-names>S. H.</given-names></name><name><surname>Lin</surname><given-names>H. C.</given-names></name><name><surname>Lin</surname><given-names>C. C.</given-names></name></person-group> (<year>2014</year>). <article-title>Health care service utilization among patients with chronic rhinosinusitis: a population-based study</article-title>. <source>Laryngoscope</source>
<volume>124</volume>, <fpage>1285</fpage>&#x02013;<lpage>1289</lpage>. <pub-id pub-id-type="doi">10.1002/lary.24500</pub-id><pub-id pub-id-type="pmid">24338913</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cincik</surname><given-names>H.</given-names></name><name><surname>Ferguson</surname><given-names>B. J.</given-names></name></person-group> (<year>2006</year>). <article-title>The impact of endoscopic cultures on care in rhinosinusitis</article-title>. <source>Laryngoscope</source>
<volume>116</volume>, <fpage>1562</fpage>&#x02013;<lpage>1568</lpage>. <pub-id pub-id-type="doi">10.1097/01.mlg.0000230402.66579.07</pub-id><pub-id pub-id-type="pmid">16954979</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>C.</given-names></name><name><surname>Garzaro</surname><given-names>M.</given-names></name><name><surname>Boggio</surname><given-names>V.</given-names></name><name><surname>Sidoti</surname><given-names>F.</given-names></name><name><surname>Simeone</surname><given-names>S.</given-names></name><name><surname>Raimondo</surname><given-names>L.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Detection of herpesviruses 1-6 and community-acquired respiratory viruses in patients with chronic rhinosinusitis with nasal polyposis</article-title>. <source>Intervirology</source>
<volume>57</volume>, <fpage>101</fpage>&#x02013;<lpage>105</lpage>. <pub-id pub-id-type="doi">10.1159/000358880</pub-id><pub-id pub-id-type="pmid">24557082</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Divekar</surname><given-names>R. D.</given-names></name><name><surname>Samant</surname><given-names>S.</given-names></name><name><surname>Rank</surname><given-names>M. A.</given-names></name><name><surname>Hagan</surname><given-names>J.</given-names></name><name><surname>Lal</surname><given-names>D.</given-names></name><name><surname>O'Brien</surname><given-names>E. K.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>Immunological profiling in chronic rhinosinusitis with nasal polyps reveals distinct VEGF and GM-CSF signatures during symptomatic exacerbations</article-title>. <source>Clin. Exp. Allergy</source>
<volume>45</volume>, <fpage>767</fpage>&#x02013;<lpage>778</lpage>. <pub-id pub-id-type="doi">10.1111/cea.12463</pub-id><pub-id pub-id-type="pmid">25429844</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dutta</surname><given-names>M.</given-names></name><name><surname>Ghatak</surname><given-names>S.</given-names></name></person-group> (<year>2013</year>). <article-title>Acute exacerbation of chronic rhinosinusitis (AECRS) with orbital complications in an atrophic rhinitis patient: a mere co-incidence?</article-title>
<source>J. Clin. Diagn. Res.</source>
<volume>7</volume>:<fpage>2973</fpage>. <pub-id pub-id-type="doi">10.7860/JCDR/2013/6461.3814</pub-id><pub-id pub-id-type="pmid">24551696</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eloy</surname><given-names>P.</given-names></name><name><surname>Poirrier</surname><given-names>A. L.</given-names></name><name><surname>De Dorlodot</surname><given-names>C.</given-names></name><name><surname>Van Zele</surname><given-names>T.</given-names></name><name><surname>Watelet</surname><given-names>J. B.</given-names></name><name><surname>Bertrand</surname><given-names>B.</given-names></name></person-group> (<year>2011</year>). <article-title>Actual concepts in rhinosinusitis: a review of clinical presentations, inflammatory pathways, cytokine profiles, remodeling, and management</article-title>. <source>Curr. Allergy Asthma Rep.</source>
<volume>11</volume>, <fpage>146</fpage>&#x02013;<lpage>162</lpage>. <pub-id pub-id-type="doi">10.1007/s11882-011-0180-0</pub-id><pub-id pub-id-type="pmid">21274665</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fokkens</surname><given-names>W. J.</given-names></name><name><surname>Lund</surname><given-names>V. J.</given-names></name><name><surname>Mullol</surname><given-names>J.</given-names></name><name><surname>Bachert</surname><given-names>C.</given-names></name><name><surname>Alobid</surname><given-names>I.</given-names></name><name><surname>Baroody</surname><given-names>F.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>European position paper on rhinosinusitis and nasal polyps 2012</article-title>. <source>Rhinology.</source><volume>50</volume>, <fpage>1</fpage>&#x02013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.4193/Rhino50E2</pub-id><pub-id pub-id-type="pmid">22469599</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gehanno</surname><given-names>P.</given-names></name><name><surname>Cohen</surname><given-names>B.</given-names></name></person-group> (<year>1993</year>). <article-title>Effectiveness and safety of ofloxacin in chronic otitis media and chronic sinusitis in adult outpatients</article-title>. <source>Eur. Arch. Oto-Rhino-Laryngol.</source>
<volume>250</volume>, <fpage>S13</fpage>&#x02013;<lpage>S14</lpage>. <pub-id pub-id-type="doi">10.1007/BF02540110</pub-id><pub-id pub-id-type="pmid">8476579</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gwaltney</surname><given-names>J. M.</given-names><suffix>Jr.</suffix></name><name><surname>Phillips</surname><given-names>C. D.</given-names></name><name><surname>Miller</surname><given-names>R. D.</given-names></name><name><surname>Riker</surname><given-names>D. K.</given-names></name></person-group> (<year>1994</year>). <article-title>Computed tomographic study of the common cold</article-title>. <source>New Engl. J. Med.</source>
<volume>330</volume>, <fpage>25</fpage>&#x02013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1056/NEJM199401063300105</pub-id><pub-id pub-id-type="pmid">8259141</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hafner</surname><given-names>B.</given-names></name><name><surname>Davris</surname><given-names>S.</given-names></name><name><surname>Riechelmann</surname><given-names>H.</given-names></name><name><surname>Mann</surname><given-names>W. J.</given-names></name><name><surname>Amedee</surname><given-names>R. G.</given-names></name></person-group> (<year>1997</year>). <article-title>Endonasal sinus surgery improves mucociliary transport in severe chronic sinusitis</article-title>. <source>Am. J. Rhinol.</source>
<volume>11</volume>, <fpage>271</fpage>&#x02013;<lpage>276</lpage>. <pub-id pub-id-type="doi">10.2500/105065897781446612</pub-id><pub-id pub-id-type="pmid">9292177</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamilos</surname><given-names>D. L.</given-names></name></person-group> (<year>2014</year>). <article-title>Host-microbial interactions in patients with chronic rhinosinusitis</article-title>. <source>J. Allergy Clin. Immunol.</source>
<volume>133</volume>, <fpage>640</fpage>&#x02013;<lpage>653</lpage>.e644. <pub-id pub-id-type="doi">10.1016/j.jaci.2013.06.049</pub-id><pub-id pub-id-type="pmid">24290275</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamilos</surname><given-names>D. L.</given-names></name></person-group> (<year>2015</year>). <article-title>Drivers of chronic rhinosinusitis: inflammation versus infection</article-title>. <source>J. Allergy Clin. Immunol.</source>
<volume>136</volume>, <fpage>1454</fpage>&#x02013;<lpage>1459</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaci.2015.10.011</pub-id><pub-id pub-id-type="pmid">26654194</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hastan</surname><given-names>D.</given-names></name><name><surname>Fokkens</surname><given-names>W.</given-names></name><name><surname>Bachert</surname><given-names>C.</given-names></name><name><surname>Newson</surname><given-names>R.</given-names></name><name><surname>Bislimovska</surname><given-names>J.</given-names></name><name><surname>Bockelbrink</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Chronic rhinosinusitis in Europe&#x02013;an underestimated disease. A GA2LEN study</article-title>. <source>Allergy</source>
<volume>66</volume>, <fpage>1216</fpage>&#x02013;<lpage>1223</lpage>. <pub-id pub-id-type="doi">10.1111/j.1398-9995.2011.02646.x</pub-id><pub-id pub-id-type="pmid">21605125</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirsch</surname><given-names>A. G.</given-names></name><name><surname>Stewart</surname><given-names>W. F.</given-names></name><name><surname>Sundaresan</surname><given-names>A. S.</given-names></name><name><surname>Young</surname><given-names>A. J.</given-names></name><name><surname>Kennedy</surname><given-names>T. L.</given-names></name><name><surname>Scott Greene</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>Nasal and sinus symptoms and chronic rhinosinusitis in a population-based sample</article-title>. <source>Allergy</source>
<volume>72</volume>, <fpage>274</fpage>&#x02013;<lpage>281</lpage>. <pub-id pub-id-type="doi">10.1111/all.13042</pub-id><pub-id pub-id-type="pmid">27590749</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoehle</surname><given-names>L. P.</given-names></name><name><surname>Phillips</surname><given-names>K. M.</given-names></name><name><surname>Bergmark</surname><given-names>R. W.</given-names></name><name><surname>Caradonna</surname><given-names>D. S.</given-names></name><name><surname>Gray</surname><given-names>S. T.</given-names></name><name><surname>Sedaghat</surname><given-names>A. R.</given-names></name></person-group> (<year>2016</year>). <article-title>Symptoms of chronic rhinosinusitis differentially impact general health-related quality of life</article-title>. <source>Rhinology</source>
<volume>54</volume>, <fpage>316</fpage>&#x02013;<lpage>322</lpage>. <pub-id pub-id-type="doi">10.4193/Rhin16.211</pub-id><pub-id pub-id-type="pmid">27665614</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoza</surname><given-names>J.</given-names></name><name><surname>Salzman</surname><given-names>R.</given-names></name><name><surname>St&#x000e1;rek</surname><given-names>I.</given-names></name><name><surname>Schalek</surname><given-names>P.</given-names></name><name><surname>Kellnerov&#x000e1;</surname><given-names>R.</given-names></name></person-group> (<year>2013</year>). <article-title>Efficacy and safety of erdosteine in the treatment of chronic rhinosinusitis with nasal polyposis-a pilot study</article-title>. <source>Rhinology</source>
<volume>51</volume>, <fpage>323</fpage>&#x02013;<lpage>327</lpage>. <pub-id pub-id-type="doi">10.4193/Rhin13.039</pub-id><pub-id pub-id-type="pmid">24260764</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huck</surname><given-names>W.</given-names></name><name><surname>Reed</surname><given-names>B. D.</given-names></name><name><surname>Nielsen</surname><given-names>R. W.</given-names></name><name><surname>Ferguson</surname><given-names>R. T.</given-names></name><name><surname>Gray</surname><given-names>D. W.</given-names></name><name><surname>Lund</surname><given-names>G. K.</given-names></name><etal/></person-group>. (<year>1993</year>). <article-title>Cefaclor vs. amoxicillin in the treatment of acute, recurrent, and chronic sinusitis</article-title>. <source>Arch. Fam. Med.</source>
<volume>2</volume>, <fpage>497</fpage>&#x02013;<lpage>503</lpage>. <pub-id pub-id-type="doi">10.1001/archfami.2.5.497</pub-id><pub-id pub-id-type="pmid">8118565</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikeda</surname><given-names>K.</given-names></name><name><surname>Yokoi</surname><given-names>H.</given-names></name><name><surname>Kusunoki</surname><given-names>T.</given-names></name><name><surname>Saitoh</surname><given-names>T.</given-names></name><name><surname>Yao</surname><given-names>T.</given-names></name><name><surname>Kase</surname><given-names>K.</given-names></name><etal/></person-group>. (<year>2011</year>). <article-title>Bacteriology of recurrent exacerbation of postoperative course in chronic rhinosinusitis in relation to asthma</article-title>. <source>Auris Nasus Larynx</source>
<volume>38</volume>, <fpage>469</fpage>&#x02013;<lpage>473</lpage>. <pub-id pub-id-type="doi">10.1016/j.anl.2010.10.009</pub-id><pub-id pub-id-type="pmid">21216117</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jackson</surname><given-names>D. J.</given-names></name><name><surname>Johnston</surname><given-names>S. L.</given-names></name></person-group> (<year>2010</year>). <article-title>The role of viruses in acute exacerbations of asthma</article-title>. <source>J. Allergy Clin. Immunol.</source>
<volume>125</volume>, <fpage>1178</fpage>&#x02013;<lpage>1187</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaci.2010.04.021</pub-id><pub-id pub-id-type="pmid">20513517</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuiper</surname><given-names>J. R.</given-names></name><name><surname>Hirsch</surname><given-names>A. G.</given-names></name><name><surname>Bandeen-Roche</surname><given-names>K.</given-names></name><name><surname>Sundaresan</surname><given-names>A. S.</given-names></name><name><surname>Tan</surname><given-names>B. K.</given-names></name><name><surname>Schleimer</surname><given-names>R. P.</given-names></name><etal/></person-group>. (<year>2018</year>). <article-title>Prevalence, severity, and risk factors for acute exacerbations of nasal and sinus symptoms by chronic rhinosinusitis status</article-title>. <source>Allergy</source>
<volume>73</volume>, <fpage>1244</fpage>&#x02013;<lpage>1253</lpage>. <pub-id pub-id-type="doi">10.1111/all.13409</pub-id><pub-id pub-id-type="pmid">29331046</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lan</surname><given-names>F.</given-names></name><name><surname>Zhang</surname><given-names>N.</given-names></name><name><surname>Holtappels</surname><given-names>G.</given-names></name><name><surname>Ruyck</surname><given-names>N. D.</given-names></name><name><surname>Krysko</surname><given-names>O.</given-names></name><name><surname>Crombruggen</surname><given-names>K. V.</given-names></name><etal/></person-group>. (<year>2018</year>). <article-title><italic>Staphylococcus aureus</italic> induces mucosal type 2 immune response via epithelial cell derived cytokines</article-title>. <source>Am. J. Respir. Crit. Care Med.</source>
<volume>198</volume>, <fpage>452</fpage>&#x02013;<lpage>463</lpage>. <pub-id pub-id-type="doi">10.1164/rccm.201710-2112OC</pub-id><pub-id pub-id-type="pmid">29768034</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>K.</given-names></name><name><surname>Pletcher</surname><given-names>S. D.</given-names></name><name><surname>Lynch</surname><given-names>S. V.</given-names></name><name><surname>Goldberg</surname><given-names>A. N.</given-names></name><name><surname>Cope</surname><given-names>E. K.</given-names></name></person-group> (<year>2018</year>). <article-title>Heterogeneity of microbiota dysbiosis in chronic rhinosinusitis: potential clinical implications and microbial community mechanisms contributing to sinonasal inflammation</article-title>. <source>Front. Cell. Infect. Microbiol.</source>
<volume>8</volume>:<fpage>168</fpage>. <pub-id pub-id-type="doi">10.3389/fcimb.2018.00168</pub-id><pub-id pub-id-type="pmid">29876323</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>B.</given-names></name><name><surname>Hu</surname><given-names>C. Y.</given-names></name><name><surname>Liu</surname><given-names>T.</given-names></name><name><surname>Liu</surname><given-names>Z.</given-names></name></person-group> (<year>2014</year>). <article-title>Respiratory viral infection in the chronic persistent phase of chronic rhinosinusitis</article-title>. <source>Laryngoscope</source>
<volume>124</volume>, <fpage>832</fpage>&#x02013;<lpage>837</lpage>. <pub-id pub-id-type="doi">10.1002/lary.24348</pub-id><pub-id pub-id-type="pmid">23929535</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>C. M.</given-names></name><name><surname>Soldanova</surname><given-names>K.</given-names></name><name><surname>Nordstrom</surname><given-names>L.</given-names></name><name><surname>Dwan</surname><given-names>M. G.</given-names></name><name><surname>Moss</surname><given-names>O. L.</given-names></name><name><surname>Contente-Cuomo</surname><given-names>T. L.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>Medical therapy reduces microbiota diversity and evenness in surgically recalcitrant chronic rhinosinusitis</article-title>. <source>Int. Forum Allergy Rhinol.</source>
<volume>3</volume>, <fpage>775</fpage>&#x02013;<lpage>781</lpage>. <pub-id pub-id-type="doi">10.1002/alr.21195</pub-id><pub-id pub-id-type="pmid">23843343</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahdavinia</surname><given-names>M.</given-names></name><name><surname>Keshavarzian</surname><given-names>A.</given-names></name><name><surname>Tobin</surname><given-names>M. C.</given-names></name><name><surname>Landay</surname><given-names>A.</given-names></name><name><surname>Schleimer</surname><given-names>R. P.</given-names></name></person-group> (<year>2016</year>). <article-title>A comprehensive review of the nasal microbiome in chronic rhinosinusitis (CRS)</article-title>. <source>Clin. Exp. Allergy</source>
<volume>46</volume>, <fpage>21</fpage>&#x02013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1111/cea.12666</pub-id><pub-id pub-id-type="pmid">26510171</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merkley</surname><given-names>M. A.</given-names></name><name><surname>Bice</surname><given-names>T. C.</given-names></name><name><surname>Grier</surname><given-names>A.</given-names></name><name><surname>Strohl</surname><given-names>A. M.</given-names></name><name><surname>Man</surname><given-names>L. X.</given-names></name><name><surname>Gill</surname><given-names>S. R.</given-names></name></person-group> (<year>2015</year>). <article-title>The effect of antibiotics on the microbiome in acute exacerbations of chronic rhinosinusitis</article-title>. <source>Int. Forum Allergy Rhinol.</source>
<volume>5</volume>, <fpage>884</fpage>&#x02013;<lpage>893</lpage>. <pub-id pub-id-type="doi">10.1002/alr.21591</pub-id><pub-id pub-id-type="pmid">26224692</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyake</surname><given-names>M. M.</given-names></name><name><surname>Bleier</surname><given-names>B. S.</given-names></name></person-group> (<year>2019</year>). <article-title>Future topical medications in chronic rhinosinusitis</article-title>. <source>Int. Forum Allergy Rhinol.</source>
<volume>9</volume>, <fpage>S32</fpage>&#x02013;<lpage>S46</lpage>. <pub-id pub-id-type="doi">10.1002/alr.22341</pub-id><pub-id pub-id-type="pmid">31087632</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Namyslowski</surname><given-names>G.</given-names></name><name><surname>Misiolek</surname><given-names>M.</given-names></name><name><surname>Czecior</surname><given-names>E.</given-names></name><name><surname>Malafiej</surname><given-names>E.</given-names></name><name><surname>Orecka</surname><given-names>B.</given-names></name><name><surname>Namyslowski</surname><given-names>P.</given-names></name><etal/></person-group> (<year>2002</year>). <article-title>Comparison of the efficacy and tolerability of amoxycillin/clavulanic acid 875 mg bid with cefuroxime 500 mg bid in the treatment of chronic and acute exacerbation of chronic sinusitis in adults</article-title>. <source>J. Chemother.</source>
<volume>14</volume>, <fpage>508</fpage>&#x02013;<lpage>517</lpage>. <pub-id pub-id-type="doi">10.1179/joc.2002.14.5.508</pub-id><pub-id pub-id-type="pmid">12462431</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oakley</surname><given-names>G. M.</given-names></name><name><surname>Harvey</surname><given-names>R. J.</given-names></name><name><surname>Lund</surname><given-names>V. J.</given-names></name></person-group> (<year>2017</year>). <article-title>The role of macrolides in chronic rhinosinusitis (CRSsNP and CRSwNP)</article-title>. <source>Curr. Allergy Asthma Rep.</source>
<volume>17</volume>:<fpage>30</fpage>. <pub-id pub-id-type="doi">10.1007/s11882-017-0696-z</pub-id><pub-id pub-id-type="pmid">28429305</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orlandi</surname><given-names>R. R.</given-names></name><name><surname>Kingdom</surname><given-names>T. T.</given-names></name><name><surname>Hwang</surname><given-names>P. H.</given-names></name><name><surname>Smith</surname><given-names>T. L.</given-names></name><name><surname>Alt</surname><given-names>J. A.</given-names></name><name><surname>Baroody</surname><given-names>F. M.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>International consensus statement on allergy and rhinology: rhinosinusitis</article-title>. <source>Int. Forum Allergy Rhinol.</source>
<volume>6</volume>(<issue>Suppl 1</issue>), <fpage>S22</fpage>&#x02013;<lpage>S209</lpage>. <pub-id pub-id-type="doi">10.1002/alr.21695</pub-id><pub-id pub-id-type="pmid">26889651</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pedersen</surname><given-names>M.</given-names></name><name><surname>Sakakura</surname><given-names>Y.</given-names></name><name><surname>Winther</surname><given-names>B.</given-names></name><name><surname>Brofeldt</surname><given-names>S.</given-names></name><name><surname>Mygind</surname><given-names>N.</given-names></name></person-group> (<year>1983</year>). <article-title>Nasal mucociliary transport, number of ciliated cells, and beating pattern in naturally acquired common colds</article-title>. <source>Eur. J. Respir. Dis. Suppl.</source>
<volume>128</volume>, <fpage>355</fpage>&#x02013;<lpage>365</lpage>.<pub-id pub-id-type="pmid">6578083</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peters</surname><given-names>A. T.</given-names></name><name><surname>Spector</surname><given-names>S.</given-names></name><name><surname>Hsu</surname><given-names>J.</given-names></name><name><surname>Hamilos</surname><given-names>D. L.</given-names></name><name><surname>Baroody</surname><given-names>F. M.</given-names></name><name><surname>Chandra</surname><given-names>R. K.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Diagnosis and management of rhinosinusitis: a practice parameter update</article-title>. <source>Ann. Allergy Asthma Immunol.</source>
<volume>113</volume>, <fpage>347</fpage>&#x02013;<lpage>385</lpage>. <pub-id pub-id-type="doi">10.1016/j.anai.2014.07.025</pub-id><pub-id pub-id-type="pmid">25256029</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phillips</surname><given-names>K. M.</given-names></name><name><surname>Hoehle</surname><given-names>L. P.</given-names></name><name><surname>Bergmark</surname><given-names>R. W.</given-names></name><name><surname>Caradonna</surname><given-names>D. S.</given-names></name><name><surname>Gray</surname><given-names>S. T.</given-names></name><name><surname>Sedaghat</surname><given-names>A. R.</given-names></name></person-group> (<year>2017</year>). <article-title>Acute exacerbations mediate quality of life impairment in chronic rhinosinusitis</article-title>. <source>J. Allergy Clin. Immunol.</source>
<volume>5</volume>, <fpage>422</fpage>&#x02013;<lpage>426</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaip.2016.09.015</pub-id><pub-id pub-id-type="pmid">27839750</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poetker</surname><given-names>D. M.</given-names></name><name><surname>Litvack</surname><given-names>J. R.</given-names></name><name><surname>Mace</surname><given-names>J. C.</given-names></name><name><surname>Smith</surname><given-names>T. L.</given-names></name></person-group> (<year>2008</year>). <article-title>Recurrent acute rhinosinusitis: presentation and outcomes of sinus surgery</article-title>. <source>Am. J. Rhinol.</source>
<volume>22</volume>, <fpage>329</fpage>&#x02013;<lpage>333</lpage>. <pub-id pub-id-type="doi">10.2500/ajr.2008.22.3177</pub-id><pub-id pub-id-type="pmid">18588769</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rank</surname><given-names>M. A.</given-names></name><name><surname>Hagan</surname><given-names>J. B.</given-names></name><name><surname>Samant</surname><given-names>S. A.</given-names></name><name><surname>Kita</surname><given-names>H.</given-names></name></person-group> (<year>2013</year>). <article-title>A proposed model to study immunologic changes during chronic rhinosinusitis exacerbations: data from a pilot study</article-title>. <source>Am. J. Rhinol. Allergy</source>
<volume>27</volume>, <fpage>98</fpage>&#x02013;<lpage>101</lpage>. <pub-id pub-id-type="doi">10.2500/ajra.2013.27.3850</pub-id><pub-id pub-id-type="pmid">23562196</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rank</surname><given-names>M. A.</given-names></name><name><surname>Wollan</surname><given-names>P.</given-names></name><name><surname>Kita</surname><given-names>H.</given-names></name><name><surname>Yawn</surname><given-names>B. P.</given-names></name></person-group> (<year>2010</year>). <article-title>Acute exacerbations of chronic rhinosinusitis occur in a distinct seasonal pattern</article-title>. <source>J. Allergy Clin. Immunol.</source>
<volume>126</volume>:<fpage>168</fpage>. <pub-id pub-id-type="doi">10.1016/j.jaci.2010.03.041</pub-id><pub-id pub-id-type="pmid">20641152</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenfeld</surname><given-names>R. M.</given-names></name><name><surname>Piccirillo</surname><given-names>J. F.</given-names></name><name><surname>Chandrasekhar</surname><given-names>S. S.</given-names></name><name><surname>Brook</surname><given-names>I.</given-names></name><name><surname>Ashok Kumar</surname><given-names>K.</given-names></name><name><surname>Kramper</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Clinical practice guideline (update): adult sinusitis</article-title>. <source>Otolaryngology</source>
<volume>152</volume>(<issue>2_Suppl.</issue>), <fpage>S1</fpage>&#x02013;<lpage>S39</lpage>. <pub-id pub-id-type="doi">10.1177/0194599815572097</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rowan</surname><given-names>N. R.</given-names></name><name><surname>Lee</surname><given-names>S.</given-names></name><name><surname>Sahu</surname><given-names>N.</given-names></name><name><surname>Kanaan</surname><given-names>A.</given-names></name><name><surname>Cox</surname><given-names>S.</given-names></name><name><surname>Phillips</surname><given-names>C. D.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>The role of viruses in the clinical presentation of chronic rhinosinusitis</article-title>. <source>Am. J. Rhinol. Allergy</source>
<volume>29</volume>, <fpage>e197</fpage>&#x02013;<lpage>e200</lpage>. <pub-id pub-id-type="doi">10.2500/ajra.2015.29.4242</pub-id><pub-id pub-id-type="pmid">26637569</pub-id></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rudmik</surname><given-names>L.</given-names></name><name><surname>Beswick</surname><given-names>D. M.</given-names></name><name><surname>Alt</surname><given-names>J. A.</given-names></name><name><surname>Bhattacharyya</surname><given-names>N.</given-names></name><name><surname>Chester</surname><given-names>A. C.</given-names></name><name><surname>Gray</surname><given-names>S. T.</given-names></name><etal/></person-group>. (<year>2018</year>). <article-title>Appropriateness criteria for surgery in the management of adult recurrent acute rhinosinusitis</article-title>. <source>Laryngoscope</source>
<volume>129</volume>, <fpage>37</fpage>&#x02013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1002/lary.27438</pub-id><pub-id pub-id-type="pmid">30284272</pub-id></mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rudmik</surname><given-names>L.</given-names></name><name><surname>Smith</surname><given-names>T. L.</given-names></name><name><surname>Schlosser</surname><given-names>R. J.</given-names></name><name><surname>Hwang</surname><given-names>P. H.</given-names></name><name><surname>Mace</surname><given-names>J. C.</given-names></name><name><surname>Soler</surname><given-names>Z. M.</given-names></name></person-group> (<year>2014</year>). <article-title>Productivity costs in patients with refractory chronic rhinosinusitis</article-title>. <source>Laryngoscope</source>
<volume>124</volume>, <fpage>2007</fpage>&#x02013;<lpage>2012</lpage>. <pub-id pub-id-type="doi">10.1002/lary.24630</pub-id><pub-id pub-id-type="pmid">24619604</pub-id></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabino</surname><given-names>H. A. C.</given-names></name><name><surname>Valera</surname><given-names>F. C. P.</given-names></name><name><surname>Aragon</surname><given-names>D. C.</given-names></name><name><surname>Fantucci</surname><given-names>M. Z.</given-names></name><name><surname>Titoneli</surname><given-names>C. C.</given-names></name><name><surname>Martinez</surname><given-names>R.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>Amoxicillin-clavulanate for patients with acute exacerbation of chronic rhinosinusitis: a prospective, double-blinded, placebo-controlled trial</article-title>. <source>Int. Forum Allergy Rhinol.</source>
<volume>7</volume>, <fpage>135</fpage>&#x02013;<lpage>142</lpage>. <pub-id pub-id-type="doi">10.1002/alr.21846</pub-id><pub-id pub-id-type="pmid">27610609</pub-id></mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schleimer</surname><given-names>R. P.</given-names></name></person-group> (<year>2017</year>). <article-title>Immunopathogenesis of chronic rhinosinusitis and nasal polyposis</article-title>. <source>Annu. Rev. Pathol.</source>
<volume>12</volume>, <fpage>331</fpage>&#x02013;<lpage>357</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-pathol-052016-100401</pub-id><pub-id pub-id-type="pmid">27959637</pub-id></mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>J.</given-names></name><name><surname>Fu</surname><given-names>Q.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Cheng</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Zhu</surname><given-names>D.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>Epidemiology of chronic rhinosinusitis: results from a cross-sectional survey in seven C hinese cities</article-title>. <source>Allergy</source>
<volume>70</volume>, <fpage>533</fpage>&#x02013;<lpage>539</lpage>. <pub-id pub-id-type="doi">10.1111/all.12577</pub-id><pub-id pub-id-type="pmid">25631304</pub-id></mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sivasubramaniam</surname><given-names>R.</given-names></name><name><surname>Douglas</surname><given-names>R.</given-names></name></person-group> (<year>2018</year>). <article-title>The microbiome and chronic rhinosinusitis. <italic>World J. Otorhinolaryngol</italic></article-title>. <source>Head Neck Surg.</source>
<volume>4</volume>, <fpage>216</fpage>&#x02013;<lpage>221</lpage>. <pub-id pub-id-type="doi">10.1016/j.wjorl.2018.08.004</pub-id></mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>K. A.</given-names></name><name><surname>Orlandi</surname><given-names>R. R.</given-names></name><name><surname>Rudmik</surname><given-names>L.</given-names></name></person-group> (<year>2015</year>). <article-title>Cost of adult chronic rhinosinusitis: a systematic review</article-title>. <source>Laryngoscope</source>
<volume>125</volume>, <fpage>1547</fpage>&#x02013;<lpage>1556</lpage>. <pub-id pub-id-type="doi">10.1002/lary.25180</pub-id><pub-id pub-id-type="pmid">25640115</pub-id></mixed-citation></ref><ref id="B62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>S. S.</given-names></name><name><surname>Evans</surname><given-names>C. T.</given-names></name><name><surname>Tan</surname><given-names>B. K.</given-names></name><name><surname>Chandra</surname><given-names>R. K.</given-names></name><name><surname>Smith</surname><given-names>S. B.</given-names></name><name><surname>Kern</surname><given-names>R. C.</given-names></name></person-group> (<year>2013</year>). <article-title>National burden of antibiotic use for adult rhinosinusitis</article-title>. <source>J. Allergy Clin. Immunol.</source>
<volume>132</volume>, <fpage>1230</fpage>&#x02013;<lpage>1232</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaci.2013.07.009</pub-id><pub-id pub-id-type="pmid">23987794</pub-id></mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sohn</surname><given-names>H. G.</given-names></name><name><surname>Park</surname><given-names>S. J.</given-names></name><name><surname>Ryu</surname><given-names>I. S.</given-names></name><name><surname>Lim</surname><given-names>H. W.</given-names></name><name><surname>Song</surname><given-names>Y. J.</given-names></name><name><surname>Yeo</surname><given-names>N.-K.</given-names></name></person-group> (<year>2018</year>). <article-title>Comparison of clinical presentation and surgical outcomes between recurrent acute rhinosinusitis and chronic rhinosinusitis</article-title>. <source>Ann. Otol. Rhinol. Laryngol.</source>
<volume>127</volume>, <fpage>763</fpage>&#x02013;<lpage>769</lpage>. <pub-id pub-id-type="doi">10.1177/0003489418792942</pub-id><pub-id pub-id-type="pmid">30095001</pub-id></mixed-citation></ref><ref id="B64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>K. S.</given-names></name><name><surname>Yan</surname><given-names>Y.</given-names></name><name><surname>Ong</surname><given-names>H. H.</given-names></name><name><surname>Chow</surname><given-names>V. T.</given-names></name><name><surname>Shi</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>D.-Y.</given-names></name></person-group> (<year>2017</year>). <article-title>Impact of respiratory virus infections in exacerbation of acute and chronic rhinosinusitis</article-title>. <source>Curr. Allergy Asthma Rep.</source>
<volume>17</volume>:<fpage>24</fpage>. <pub-id pub-id-type="doi">10.1007/s11882-017-0693-2</pub-id><pub-id pub-id-type="pmid">28389843</pub-id></mixed-citation></ref><ref id="B65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tieu</surname><given-names>D. D.</given-names></name><name><surname>Kern</surname><given-names>R. C.</given-names></name><name><surname>Schleimer</surname><given-names>R. P.</given-names></name></person-group> (<year>2009</year>). <article-title>Alterations in epithelial barrier function and host defense responses in chronic rhinosinusitis</article-title>. <source>J. Allergy Clin. Immunol.</source>
<volume>124</volume>, <fpage>37</fpage>&#x02013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaci.2009.04.045</pub-id><pub-id pub-id-type="pmid">19560577</pub-id></mixed-citation></ref><ref id="B66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wagner</surname><given-names>B. M.</given-names></name><name><surname>Waite</surname><given-names>D. W.</given-names></name><name><surname>Hoggard</surname><given-names>M.</given-names></name><name><surname>Taylor</surname><given-names>M. W.</given-names></name><name><surname>Biswas</surname><given-names>K.</given-names></name><name><surname>Douglas</surname><given-names>R. G.</given-names></name></person-group> (<year>2017</year>). <article-title>Moving beyond descriptions of diversity: clinical and research implications of bacterial imbalance in chronic rhinosinusitis</article-title>. <source>Rhinology</source>
<volume>55</volume>, <fpage>291</fpage>&#x02013;<lpage>297</lpage>. <pub-id pub-id-type="doi">10.4193/Rhin17.135</pub-id><pub-id pub-id-type="pmid">28988258</pub-id></mixed-citation></ref><ref id="B67"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Watanabe</surname><given-names>S.</given-names></name><name><surname>Matsukura</surname><given-names>S.</given-names></name><name><surname>Suzaki</surname><given-names>H.</given-names></name></person-group> (<year>2009</year>). <article-title>Double-stranded RNA poly (I: C) enhances matrix metalloproteinase mRNA expression in human nasal polyp epithelial cells</article-title>. <source>Acta Otolaryngol.</source>
<volume>129</volume>, <fpage>105</fpage>&#x02013;<lpage>109</lpage>. <pub-id pub-id-type="doi">10.1080/00016480902911979</pub-id></mixed-citation></ref><ref id="B68"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>N.</given-names></name><name><surname>Glorieux</surname><given-names>S.</given-names></name><name><surname>Holtappels</surname><given-names>G.</given-names></name><name><surname>Vaneechoutte</surname><given-names>M.</given-names></name><name><surname>Krysko</surname><given-names>O.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>Herpes simplex virus type 1 infection facilitates invasion of <italic>Staphylococcus aureus</italic> into the nasal mucosa and nasal polyp tissue</article-title>. <source>PLoS ONE</source>
<volume>7</volume>:<fpage>e39875</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0039875</pub-id><pub-id pub-id-type="pmid">22768151</pub-id></mixed-citation></ref><ref id="B69"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wood</surname><given-names>A. J.</given-names></name><name><surname>Antoszewska</surname><given-names>H.</given-names></name><name><surname>Fraser</surname><given-names>J.</given-names></name><name><surname>Douglas</surname><given-names>R. G.</given-names></name></person-group> (<year>2011</year>). <article-title>Is chronic rhinosinusitis caused by persistent respiratory virus infection?</article-title>
<source>Int. Forum Allergy Rhinol.</source>
<volume>1</volume>, <fpage>95</fpage>&#x02013;<lpage>100</lpage>. <pub-id pub-id-type="doi">10.1002/alr.20030</pub-id><pub-id pub-id-type="pmid">22287325</pub-id></mixed-citation></ref><ref id="B70"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamasaki</surname><given-names>A.</given-names></name><name><surname>Hoehle</surname><given-names>L. P.</given-names></name><name><surname>Phillips</surname><given-names>K. M.</given-names></name><name><surname>Feng</surname><given-names>A. L.</given-names></name><name><surname>Campbell</surname><given-names>A. P.</given-names></name><name><surname>Caradonna</surname><given-names>D. S.</given-names></name><etal/></person-group>. (<year>2018</year>). <article-title>Association between systemic antibiotic and corticosteroid use for chronic rhinosinusitis and quality of life</article-title>. <source>Laryngoscope</source>
<volume>128</volume>, <fpage>37</fpage>&#x02013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1002/lary.26778</pub-id><pub-id pub-id-type="pmid">28731529</pub-id></mixed-citation></ref><ref id="B71"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yeo</surname><given-names>N. K.</given-names></name><name><surname>Jang</surname><given-names>Y. J.</given-names></name></person-group> (<year>2010</year>). <article-title>Rhinovirus infection-induced alteration of tight junction and adherens junction components in human nasal epithelial cells</article-title>. <source>Laryngoscope</source>
<volume>120</volume>, <fpage>346</fpage>&#x02013;<lpage>352</lpage>. <pub-id pub-id-type="doi">10.1002/lary.20764</pub-id><pub-id pub-id-type="pmid">20013846</pub-id></mixed-citation></ref><ref id="B72"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>Z.</given-names></name><name><surname>Tang</surname><given-names>W.</given-names></name><name><surname>Ray</surname><given-names>A.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Einarsson</surname><given-names>O.</given-names></name><name><surname>Landry</surname><given-names>M. L.</given-names></name><etal/></person-group>. (<year>1996</year>). <article-title>Rhinovirus stimulation of interleukin-6 <italic>in vivo</italic> and <italic>in vitro</italic>. Evidence for nuclear factor kappa B-dependent transcriptional activation</article-title>. <source>J. Clin. Invest.</source>
<volume>97</volume>, <fpage>421</fpage>&#x02013;<lpage>430</lpage>. <pub-id pub-id-type="doi">10.1172/JCI118431</pub-id><pub-id pub-id-type="pmid">8567963</pub-id></mixed-citation></ref></ref-list></back></article>